Related Experiment Videos
The need for evidence in hypertension management: historical perspective
1Internal Medicine Section, King Faisal Specialist Hospital & Research Centre, Department of Medicine, Riyadh, Saudi Arabia. moawad@kfshrc.edu.sa
Insights
Diuretics remain the preferred initial treatment for hypertension, yet many clinicians overlook this guideline. Adhering to recommendations for thiazide-diuretics can significantly reduce global hypertension treatment costs.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- The National Heart, Lung, and Blood Institute introduced algorithmic hypertension treatment in 1973, establishing the stepped-care approach.
- Initial recommendations favored diuretics, evolving through Joint National Committee (JNC) reports to include beta-blockers, calcium channel blockers (CCBs), and angiotensin-converting enzyme (ACE) inhibitors.
- Despite evolving guidelines and resolved safety concerns with newer drug classes, thiazide-diuretics are consistently recommended as preferred initial therapy for hypertension.
Purpose of the Study:
- To review the historical evolution of hypertension treatment guidelines.
- To highlight the persistent recommendation for thiazide-diuretics as first-line therapy.
- To examine the discrepancy between guideline recommendations and clinical practice in hypertension management.
Main Methods:
- Historical review of JNC reports and international hypertension guidelines.
- Analysis of drug class recommendations for initial antihypertensive therapy.
- Discussion of the J-curve hypothesis and its impact on treatment thresholds.
- Examination of adherence to guideline recommendations in clinical practice.
Main Results:
- Diuretics were initially recommended, with subsequent guidelines expanding options but often retaining diuretics or beta-blockers as preferred initial agents.
- Safety concerns with ACE inhibitors and CCBs have largely been addressed.
- Despite evidence supporting the "lower the blood pressure the better" concept, especially in certain conditions, and consistent recommendations for thiazide-diuretics, many clinicians do not follow these guidelines.
- Non-adherence to preferred initial therapy contributes significantly to global hypertension treatment costs.
Conclusions:
- Thiazide-diuretics are recommended as the preferred initial pharmacologic treatment for hypertension.
- Clinical practice often deviates from established guidelines, potentially increasing healthcare costs.
- Further efforts are needed to ensure adherence to evidence-based hypertension treatment protocols.
Abstract:
The Task Force of the National Heart, Lung and Blood institute issued the first standardized, algorithmic approach to treating hypertension in 1973. The concept of a stepped-care approach was born at that time. Their initial recommendation for antihypertensive drug therapy was diuretics. Subsequent Joint National Committee (JNC) Reports on Detection, Evaluation, and Treatment of High Blood Pressure recommended that initial drug therapy be either a diuretic or beta-adrenergic blocker, and then either of these two drugs, and then a calcium channel blocker (CCB) or an angiotensin-converting enzyme inhibitor (ACE-inhibitors). The JNC-V then recommended any of the four classes or an alpha-beta-blocker as initial therapy, but diuretics and b-blockers were preferable. That diuretics or beta-blockers should be the initial drug for noncomplicated hypertensive patient was also the recommendation of the Sixth Joint National committee report. Safety issues that arose after introduction ACE inhibitors and CCBs have since been mostly resolved. Drug treatment thresholds varied among the US, Canadian, British and WHO/ISH recommendations despite the fact that all were based on the same set of data. The concept of "the lower the blood pressure the better without causing symptoms" was the rule until the J-curve hypothesis emerged and generated a long debate. Now the current evidence supports the old concept, at least for some conditions such as hypertension in diabetic patients or in those with nephrotic-range proteinuria. Despite the repeated recommendations that thiazide-diuretics are preferred as the initial agent in hypertension treatment, many clinicians ignore these guidelines. This practice has added a signficant cost to hypertension treatment worldwide.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hypertension V: Nursing Management
Hypertension I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications
Errors occurring during blood pressure monitoring
Several factors...